IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_ncomms14321.html
   My bibliography  Save this article

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein

Author

Listed:
  • B. A. Krishna

    (Addenbrooke’s Hospital, University of Cambridge)

  • K. Spiess

    (Laboratory for Molecular Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen)

  • E. L. Poole

    (Addenbrooke’s Hospital, University of Cambridge)

  • B. Lau

    (Addenbrooke’s Hospital, University of Cambridge
    Present address: Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, United Kingdom)

  • S. Voigt

    (Robert Koch Institute
    Charité-Universitätsmedizin)

  • T. N. Kledal

    (Section for Virology, The National Veterinary Institute, Technical University of Denmark)

  • M. M. Rosenkilde

    (Laboratory for Molecular Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen)

  • J. H. Sinclair

    (Addenbrooke’s Hospital, University of Cambridge)

Abstract

Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. In vivo, myeloid cells and their progenitors are an important site of HCMV latency, and one viral gene expressed by latently infected myeloid cells is US28. This viral gene encodes a cell surface G protein-coupled receptor (GPCR) that binds chemokines, triggering its endocytosis. We show that the expression of US28 on the surface of latently infected cells allows monocytes and their progenitor CD34+ cells to be targeted and killed by F49A-FTP, a highly specific fusion toxin protein that binds this viral GPCR. As expected, this specific targeting of latently infected cells by F49A-FTP also robustly reduces virus reactivation in vitro. Consequently, such specific fusion toxin proteins could form the basis of a therapeutic strategy for eliminating latently infected cells before haematopoietic stem cell transplantation.

Suggested Citation

  • B. A. Krishna & K. Spiess & E. L. Poole & B. Lau & S. Voigt & T. N. Kledal & M. M. Rosenkilde & J. H. Sinclair, 2017. "Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein," Nature Communications, Nature, vol. 8(1), pages 1-9, April.
    • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14321
    DOI: 10.1038/ncomms14321
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms14321
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms14321?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14321. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.